Since platelets and erythrocytes also exhibit CD47, the Sendai virus and anti-CD47 were packaged in PLGA nanoparticles for superior accumulation in the tumour microenvironment and to reduce non-specific disruption of the normal blood cells and platelets. Here, CD47 is linked to neoplasm.